{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-002855","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.850119+00:00","generated_at":"2026-05-28T03:09:59.625917+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Adial Pharmaceuticals updates business development presentation for upcoming meetings","bullets":["Company will hold business development meetings over the next several weeks.","Updated business development presentation furnished as Exhibit 99.1.","Presentation includes forward-looking statements under safe harbor provisions.","No specific financial data, milestones, or material changes disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-002855","json":"https://secwatch.observer/filing/0001213900-25-002855.json","markdown":"https://secwatch.observer/filing/0001213900-25-002855.md","text":"https://secwatch.observer/filing/0001213900-25-002855.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025002855/0001213900-25-002855-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025002855/ea0227475-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:09:59.625917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}